As of 2025-05-15, the Intrinsic Value of GE Healthcare Technologies Inc (GEHC) is 86.10 USD. This GEHC valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 72.84 USD, the upside of GE Healthcare Technologies Inc is 18.20%.
The range of the Intrinsic Value is 57.86 - 158.16 USD
Based on its market price of 72.84 USD and our intrinsic valuation, GE Healthcare Technologies Inc (GEHC) is undervalued by 18.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 57.86 - 158.16 | 86.10 | 18.2% |
| DCF (Growth 10y) | 67.01 - 170.14 | 96.44 | 32.4% |
| DCF (EBITDA 5y) | 115.03 - 180.59 | 144.66 | 98.6% |
| DCF (EBITDA 10y) | 109.25 - 190.33 | 143.97 | 97.6% |
| Fair Value | 119.26 - 119.26 | 119.26 | 63.72% |
| P/E | 103.32 - 182.00 | 139.50 | 91.5% |
| EV/EBITDA | 126.21 - 187.55 | 161.74 | 122.1% |
| EPV | 30.74 - 57.22 | 43.98 | -39.6% |
| DDM - Stable | 36.33 - 90.46 | 63.39 | -13.0% |
| DDM - Multi | 50.06 - 98.08 | 66.41 | -8.8% |
| Market Cap (mil) | 33,349.07 |
| Beta | 1.21 |
| Outstanding shares (mil) | 457.84 |
| Enterprise Value (mil) | 39,694.07 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.97% |
| Cost of Debt | 11.63% |
| WACC | 8.97% |